Cary J. Claiborne
2021 - ADIAL PHARMACEUTICALS
In 2021, Cary J. Claiborne earned a total compensation of $466.8K as Chief Executive Officer since August 18, 2022; Former Chief Operating Officer and Member of the Board of Directors at ADIAL PHARMACEUTICALS.
Compensation breakdown
| Option Awards | $447,650 |
|---|---|
| Salary | $15,200 |
| Other | $3,913 |
| Total | $466,763 |
Claiborne received $447.7K in option awards, accounting for 96% of the total pay in 2021.
Claiborne also received $15.2K in salary and $3.9K in other compensation.
Rankings
In 2021, Cary J. Claiborne's compensation ranked 10,857th out of 12,412 executives tracked by ExecPay. In other words, Claiborne earned more than 12.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,857 out of 12,412 | 13th |
Division Manufacturing | 4,780 out of 5,498 | 13th |
Major group Chemicals And Allied Products | 2,147 out of 2,374 | 10th |
Industry group Drugs | 1,909 out of 2,095 | 9th |
Industry Pharmaceutical Preparations | 1,410 out of 1,542 | 9th |
Source: SEC filing on September 1, 2022.
Claiborne's colleagues
We found two more compensation records of executives who worked with Cary J. Claiborne at ADIAL PHARMACEUTICALS in 2021.